Gmh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 09-12-2024
- Paid Up Capital ₹ 1.49 M
as on 09-12-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.30 M
as on 09-12-2024
- Satisfied Charges ₹ 7.80 Cr
as on 09-12-2024
- Revenue -12.14%
(FY 2023)
- Profit -18.32%
(FY 2023)
- Ebitda -55.68%
(FY 2023)
- Net Worth 3.50%
(FY 2023)
- Total Assets -6.20%
(FY 2023)
About Gmh Pharmaceuticals
The Corporate was formerly known as Gmh Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.49 M.
The company currently has active open charges totaling ₹3.30 M. The company has closed loans amounting to ₹7.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ram Gopal and Ankur Goyal serve as directors at the Company.
- CIN/LLPIN
U24232CH1994PTC014857
- Company No.
014857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationChandigarh, Chandigarh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gmh Pharmaceuticals Pvt Ltd offer?
Gmh Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Common Disease Medicines, Allopathic Cough Syrup, Digestive System Drugs & Medicines, Pantoprazole Drugs, Antihistamines.
Who are the key members and board of directors at Gmh Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Gopal  | Director | 26-Jul-1994 | Current |
| Ankur Goyal | Director | 23-Jun-2011 | Current |
Financial Performance of Gmh Pharmaceuticals.
Gmh Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.14% decrease. The company also saw a substantial fall in profitability, with a 18.32% decrease in profit. The company's net worth moved up by a moderate rise of 3.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gmh Pharmaceuticals?
Unlock access to Gmh Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kingston Aqua Industries Private Limited.Active 16 years 4 monthsRam Gopal and Ankur Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab & Sind Bank Creation Date: 04 Jan 2005 | ₹1.50 M | Open |
Central Bank Of India Creation Date: 17 Mar 1993 | ₹1.80 M | Open |
Small Industries Devlopment Bank Of India Creation Date: 27 Mar 2012 | ₹7.50 M | Satisfied |
How Many Employees Work at Gmh Pharmaceuticals?
Unlock and access historical data on people associated with Gmh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gmh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gmh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
